Companies / Kuwait
Dar Al Dawa Beats Expectations
November 2006 | Company Finance AlertJordanian drugmaker Dar Al Dawa (DAD) has announced a 19.2% growth in sales for the first three quarters of the year to JOD28.36 (US$40.02mn). On the back of this strong performance full year sales are forecast to exceed expectations and reach JOD36.78mn (US$51.92mn). Meanwhile, profit for 9M06 stood at a healthy JOD7.2mn (US$10.16mn).
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.



